The expansion will increase the number and consistency of conditions screened through newborn bloodspot screening (NBS) programs across Australia.
This is an open consultation, and anyone interested in, or impacted by, NBS is invited to respond.
This includes all parents, families, clinicians, laboratory and hospital staff, and other clinical and technical experts.
Australian NBS programs are a preventative public health success story. The programs have saved and improved the lives of thousands of Australian babies since newborn bloodspot screening began in the 1960s.
In 2022, the Australian Government has committed to expand NBS programs to include more conditions and ensure consistency of the programs across Australia.
To do this, we need your help.
Consultation: Expansion of Newborn Bloodspot Screening
We value the diverse perspectives, experiences and knowledge of all stakeholders and interested members of the community. This paper seeks to ensure that that people's views are included, heard and used to inform the expansion of NBS.
You can learn more about NBS programs, and provide input at our Consultation Hub until Monday 12 December 2022. Responses to the paper should take between 15 to 30 minutes to complete.
Read more information on the Newborn bloodspot screening.
Please contact NBS@health.gov.au if you have any questions.